S100A8 and myelodysplastic syndrome: The inflammatory environment in the MDS bone marrow contains inflammation associated signaling molecules, such as the danger-associated molecular pattern (DAMP) heterodimer S100A8/S100A9 that will interact with its ligand CD33 on MDSCs.